Comparison of [177Lu-DOTA0,Tyr3]octreotate and [177Lu-DOTA0,Tyr3]octreotide: which peptide is preferable for PRRT?

Author: Esser J.   Krenning E.   Teunissen J.   Kooij P.   Gameren A.   Bakker W.   Kwekkeboom D.  

Publisher: Springer Publishing Company

ISSN: 1619-7070

Source: European Journal of Nuclear Medicine and Molecular Imaging, Vol.33, Iss.11, 2006-11, pp. : 1346-1351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content